Comparison of Aclidinium Bromide and Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Summary

This exploratory study will compare the efficacy of the fixed-dose combination (FDC) of aclidinium bromide and formoterol fumarate once daily in the morning and placebo once in the evening vs. the FDC once daily in the morning and formoterol fumarate once in the evening vs. formoterol fumarate twice daily. The study will assess pulmonary function and symptoms in patients with moderate to severe COPD.

Timeline

Start

2008-06-30

Primary completion

2008-11-11

Completion

2008-11-11

Outcome

Outcome not reported

Stopped: “Actual sample size of 156 was sufficient to estimate the clinical outcomes.”

Drugs

Indications